Impact of vancomycin on sarA-mediated biofilm formation: Role in persistent endovascular infections due to methicillin-resistant staphylococcus aureus

Wessam Abdelhady, Arnold S. Bayer, Kati Seidl, Derek E. Moormeier, Kenneth W Bayles, Ambrose Cheung, Michael R. Yeaman, Yan Q. Xiong

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background. Staphylococcus aureus is the most common cause of endovascular infections. The staphylococcal accessory regulator A locus (sarA) is a major virulence determinant that may potentially impact methicillin-resistant S. aureus (MRSA) persistence in such infections via its influence on biofilm formation.Methods. Two healthcare-associated MRSA isolates from patients with persistent bacteremia and 2 prototypical community-acquired MRSA strains, as well as their respective isogenic sarA mutants, were studied for in vitro biofilm formation, fibronectin-binding capacity, autolysis, and protease and nuclease activities. These assays were done in the presence or absence of sub-minimum inhibitory concentrations (MICs) of vancomycin. In addition, these strain pairs were compared for intrinsic virulence and responses to vancomycin therapy in experimental infective endocarditis, a prototypical biofilm model.Results. All sarA mutants displayed significantly reduced biofilm formation and binding to fibronectin but increased protease production in vitro, compared with their respective parental strains. Interestingly, exposure to sub-MICs of vancomycin significantly promoted biofilm formation and fibronectin-binding in parental strains but not in sarA mutants. In addition, all sarA mutants became exquisitely susceptible to vancomycin therapy, compared with their respective parental strains, in the infective endocarditis model.Conclusions. These observations suggest that sarA activation is important in persistent MRSA endovascular infection, potentially in the setting of biofilm formation.

Original languageEnglish (US)
Pages (from-to)1231-1240
Number of pages10
JournalJournal of Infectious Diseases
Volume209
Issue number8
DOIs
StatePublished - Apr 15 2014

Fingerprint

Vancomycin
Methicillin-Resistant Staphylococcus aureus
Biofilms
Infection
Fibronectins
Microbial Sensitivity Tests
Endocarditis
Virulence
Peptide Hydrolases
Autolysis
Investigational Therapies
Bacteremia
Staphylococcus aureus
Delivery of Health Care

Keywords

  • MRSA endocarditis
  • biofilm formation
  • sarA

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Impact of vancomycin on sarA-mediated biofilm formation : Role in persistent endovascular infections due to methicillin-resistant staphylococcus aureus. / Abdelhady, Wessam; Bayer, Arnold S.; Seidl, Kati; Moormeier, Derek E.; Bayles, Kenneth W; Cheung, Ambrose; Yeaman, Michael R.; Xiong, Yan Q.

In: Journal of Infectious Diseases, Vol. 209, No. 8, 15.04.2014, p. 1231-1240.

Research output: Contribution to journalArticle

Abdelhady, Wessam ; Bayer, Arnold S. ; Seidl, Kati ; Moormeier, Derek E. ; Bayles, Kenneth W ; Cheung, Ambrose ; Yeaman, Michael R. ; Xiong, Yan Q. / Impact of vancomycin on sarA-mediated biofilm formation : Role in persistent endovascular infections due to methicillin-resistant staphylococcus aureus. In: Journal of Infectious Diseases. 2014 ; Vol. 209, No. 8. pp. 1231-1240.
@article{c22d72c0a17e4da88f56182c63c90b59,
title = "Impact of vancomycin on sarA-mediated biofilm formation: Role in persistent endovascular infections due to methicillin-resistant staphylococcus aureus",
abstract = "Background. Staphylococcus aureus is the most common cause of endovascular infections. The staphylococcal accessory regulator A locus (sarA) is a major virulence determinant that may potentially impact methicillin-resistant S. aureus (MRSA) persistence in such infections via its influence on biofilm formation.Methods. Two healthcare-associated MRSA isolates from patients with persistent bacteremia and 2 prototypical community-acquired MRSA strains, as well as their respective isogenic sarA mutants, were studied for in vitro biofilm formation, fibronectin-binding capacity, autolysis, and protease and nuclease activities. These assays were done in the presence or absence of sub-minimum inhibitory concentrations (MICs) of vancomycin. In addition, these strain pairs were compared for intrinsic virulence and responses to vancomycin therapy in experimental infective endocarditis, a prototypical biofilm model.Results. All sarA mutants displayed significantly reduced biofilm formation and binding to fibronectin but increased protease production in vitro, compared with their respective parental strains. Interestingly, exposure to sub-MICs of vancomycin significantly promoted biofilm formation and fibronectin-binding in parental strains but not in sarA mutants. In addition, all sarA mutants became exquisitely susceptible to vancomycin therapy, compared with their respective parental strains, in the infective endocarditis model.Conclusions. These observations suggest that sarA activation is important in persistent MRSA endovascular infection, potentially in the setting of biofilm formation.",
keywords = "MRSA endocarditis, biofilm formation, sarA",
author = "Wessam Abdelhady and Bayer, {Arnold S.} and Kati Seidl and Moormeier, {Derek E.} and Bayles, {Kenneth W} and Ambrose Cheung and Yeaman, {Michael R.} and Xiong, {Yan Q.}",
year = "2014",
month = "4",
day = "15",
doi = "10.1093/infdis/jiu007",
language = "English (US)",
volume = "209",
pages = "1231--1240",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Impact of vancomycin on sarA-mediated biofilm formation

T2 - Role in persistent endovascular infections due to methicillin-resistant staphylococcus aureus

AU - Abdelhady, Wessam

AU - Bayer, Arnold S.

AU - Seidl, Kati

AU - Moormeier, Derek E.

AU - Bayles, Kenneth W

AU - Cheung, Ambrose

AU - Yeaman, Michael R.

AU - Xiong, Yan Q.

PY - 2014/4/15

Y1 - 2014/4/15

N2 - Background. Staphylococcus aureus is the most common cause of endovascular infections. The staphylococcal accessory regulator A locus (sarA) is a major virulence determinant that may potentially impact methicillin-resistant S. aureus (MRSA) persistence in such infections via its influence on biofilm formation.Methods. Two healthcare-associated MRSA isolates from patients with persistent bacteremia and 2 prototypical community-acquired MRSA strains, as well as their respective isogenic sarA mutants, were studied for in vitro biofilm formation, fibronectin-binding capacity, autolysis, and protease and nuclease activities. These assays were done in the presence or absence of sub-minimum inhibitory concentrations (MICs) of vancomycin. In addition, these strain pairs were compared for intrinsic virulence and responses to vancomycin therapy in experimental infective endocarditis, a prototypical biofilm model.Results. All sarA mutants displayed significantly reduced biofilm formation and binding to fibronectin but increased protease production in vitro, compared with their respective parental strains. Interestingly, exposure to sub-MICs of vancomycin significantly promoted biofilm formation and fibronectin-binding in parental strains but not in sarA mutants. In addition, all sarA mutants became exquisitely susceptible to vancomycin therapy, compared with their respective parental strains, in the infective endocarditis model.Conclusions. These observations suggest that sarA activation is important in persistent MRSA endovascular infection, potentially in the setting of biofilm formation.

AB - Background. Staphylococcus aureus is the most common cause of endovascular infections. The staphylococcal accessory regulator A locus (sarA) is a major virulence determinant that may potentially impact methicillin-resistant S. aureus (MRSA) persistence in such infections via its influence on biofilm formation.Methods. Two healthcare-associated MRSA isolates from patients with persistent bacteremia and 2 prototypical community-acquired MRSA strains, as well as their respective isogenic sarA mutants, were studied for in vitro biofilm formation, fibronectin-binding capacity, autolysis, and protease and nuclease activities. These assays were done in the presence or absence of sub-minimum inhibitory concentrations (MICs) of vancomycin. In addition, these strain pairs were compared for intrinsic virulence and responses to vancomycin therapy in experimental infective endocarditis, a prototypical biofilm model.Results. All sarA mutants displayed significantly reduced biofilm formation and binding to fibronectin but increased protease production in vitro, compared with their respective parental strains. Interestingly, exposure to sub-MICs of vancomycin significantly promoted biofilm formation and fibronectin-binding in parental strains but not in sarA mutants. In addition, all sarA mutants became exquisitely susceptible to vancomycin therapy, compared with their respective parental strains, in the infective endocarditis model.Conclusions. These observations suggest that sarA activation is important in persistent MRSA endovascular infection, potentially in the setting of biofilm formation.

KW - MRSA endocarditis

KW - biofilm formation

KW - sarA

UR - http://www.scopus.com/inward/record.url?scp=84897415764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897415764&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiu007

DO - 10.1093/infdis/jiu007

M3 - Article

C2 - 24403556

AN - SCOPUS:84897415764

VL - 209

SP - 1231

EP - 1240

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 8

ER -